NOX 1.52% 6.7¢ noxopharm limited

Ann: Licencing Deal Expands Noxopharm Drug Opportunities, page-5

  1. 580 Posts.
    lightbulb Created with Sketch. 355
    Well. This is an exciting turn of events. Having a solution to the inflammatory side effects of mRNA vaccines alone has multi billion dollar value, leaving aside all the other potential assets coming out of Pharmorage. Great space to be in at the moment.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.